Cancer Research AMC Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, W. C.
Right arrow Articles by Augenlicht, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, W. C.
Right arrow Articles by Augenlicht, L. H.
[Cancer Research 61, 565-569, January 15, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

Targeted Inactivation of the p21WAF1/cip1 Gene Enhances Apc-initiated Tumor Formation and the Tumor-promoting Activity of a Western-Style High-Risk Diet by Altering Cell Maturation in the Intestinal Mucosa1

Wan Cai Yang, Joseph Mathew, Anna Velcich, Winfried Edelmann, Raju Kucherlapati, Martin Lipkin, Kan Yang and Leonard H. Augenlicht2

Albert Einstein Cancer Center, Bronx, 10467 [W. C. Y., J. M., A. V., W. E., R. K., L. H. A.], and Strang Cancer Prevention Center, New York, New York 10021 [M. L., K. Y.]


   ABSTRACT
Top
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Elimination of both alleles of the gene that encodes the cyclin kinase inhibitor p21WAF1/cip1 increases the frequency and size of intestinal tumors in Apc1638+/- mice that inherit a mutant allele of the Apc gene, and intermediate effects are seen if a single p21 allele is inactivated. The increased tumor formation is associated with altered cell maturation in the intestinal mucosa of the p21-deficient mice—increased cell proliferation, and decreased apoptosis, and goblet cell differentiation—that is also a function of p21 gene dosage. Moreover, a Western-style diet that mimics principal risk factors for colon cancer (high fat and phosphate, low calcium and vitamin D) accelerates tumor formation in Apc1638+/- mice, and the loss of a single or both p21 alleles is additive with the tumor-promoting effects of this diet, resulting in more and larger tumors, and a highly significant decrease in survival time. Thus, p21 normally suppresses Apc-initiated tumor formation and is haplo-insufficient in this regard. This is consistent with recent reports that Apc initiates tumor formation by up-regulating c-myc expression through altered ß-catenin-Tcf signaling and that c-myc then up-regulates cdk4, whose activity is inhibited by p21. Decreased expression of p21 is also a marker of poor prognosis in patients, and the data presented suggest that dietary alterations in patients undergoing treatment for colon cancer might be highly effective in improving outcome.


   INTRODUCTION
Top
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The p21WAF1/cip1 gene, a downstream effector of p53 (1) , is an inhibitor of cyclin-dependent kinase activity (2) and is therefore an important regulator of the cell cycle and potentially, of apoptosis and cell differentiation. In the intestinal tract, p21 is expressed as cells exit the proliferative compartment, and loss of both expression and topological regulation is detected early in colon tumor formation (3 , 4) . Absence of p21 is linked to inability of colon tumor cells to arrest in the G1 phase of the cell cycle (5 , 6) , and the cell cycle arrest and apoptosis of colon tumor cells stimulated by the short-chain fatty acid butyrate, the nonsteroidal anti-inflammatory drug sulindac, and radiation are all linked to induction of p21 (6, 7, 8, 9, 10, 11) .

Despite this evidence for an important role of p21 in the regulation of intestinal cell maturation and tumor formation, the targeted inactivation of the p21 gene in mice does not result in an obvious phenotype in the intestinal tract or other organs, although embryonic fibroblasts derived from such mice are defective in G1 checkpoint arrest (12) . However, it is possible that the loss of p21 is important in the formation of tumors that are initiated by other genetic events. In particular, loss of the wild-type APC gene initiates the development of almost all human colon cancers (13) , and mice that inherit an inactivated Apc allele develop intestinal tumors, principally in the small intestine, when they spontaneously lose or inactivate the remaining wild-type Apc allele (14, 15, 16, 17, 18) . Moreover, because Apc up-regulates c-myc expression through defective ß-catenin-Tcf signaling (19) and c-myc then up-regulates cdk4 (20) , a prediction is that p21, an inhibitor of cdk4 activity, should have important effects on the initiation of tumors by Apc.

Therefore, to determine whether p21 could alter intestinal tumorigenesis initiated by loss of Apc, we generated mice that inherited a mutant Apc allele and that were also either heterozygous or homozygous for loss of p21 and found that loss of p21 enhanced tumor formation in a dosage-dependent manner. Further, this increased tumorigenesis was associated with striking effects on cell maturation in the intestinal mucosa. Finally, because a Western-style diet has been shown to act on later stages of tumor promotion in enhancing Apc-initiated tumor formation, we investigated whether the loss of p21 was additive with a Western-style diet. Additive effects on tumor number and size were indeed seen, resulting in a highly significant decrease in life span for the mice. Thus, the combination of p21 loss and a Western-style diet has a profound impact on survival of mice with Apc-initiated tumors, which mimics the poorer prognosis for colon cancer patients whose tumors show decreased p21 expression (21) .


   MATERIALS AND METHODS
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
The Apc1638 and p21 mouse models and methods for genotyping have been reported (12 , 16, 17, 18) . Apc1638+/- mice were mated with p21-/- mice to produce Apc1638+/-,p21+/- offspring (F1). F1 mice were mated to produce desired genotypes: Apc1638+/-,p21+/+, +/-, or -/-. At weaning (approximately 3–4 weeks), littermates were randomized to genetic/dietary groups and fed ad libitum either AIN76A or a Western-style diet that is formulated on the basis of nutrient density to mimic major risk factors for colon cancer in the Western diet: high in fat and phosphate and low in calcium and vitamin D (22 , 23) . Diets were from Teklad (Madison, WI).

Mice were weighed weekly and maintained on diet for 36 weeks or until they exhibited significant weight loss or other signs of extensive tumor formation. Mice were killed by CO2 overdose and cervical dislocation and rapidly dissected for evaluation of tumors and fixation of tissues, as described previously (16 , 18) . Proliferation and apoptosis were evaluated by staining for proliferating cell nuclear antigen (Zymed, South San Francisco, CA) or TUNEL3 assay (Trevigen, Gaithersburg, MD), as described previously (24) . Goblet cells were detected by staining for mucins with Alcian blue or by immunohistochemical detection of mucins with MCM antibody (Ref. 25 ; a generous gift of A. Einerhand, The University of Amsterdam, The Netherlands), with detection by immunoperoxidase, using an ABC kit (Vector Laboratories, Burlingame, CA).


   RESULTS
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Apc1638+/- mice were mated with p21-/- mice to produce Apc+/-,p21+/- offspring (F1). The F1 mice were then mated to produce mice that were Apc+/-,p21+/+, +/-, or -/- (F2). By 36 weeks on a defined AIN76A diet, the F2 Apc+/-,p21+/+ mice developed intestinal tumors in 60% of the animals, at a frequency of 1.7 tumors per mouse (Fig. 1)Citation . This tumor incidence and frequency were identical to that of Apc1638+/- mice on a homogeneous B6 background (18) , thus eliminating the possibility that unlinked loci from the p21 mice had a significant effect on the Apc-initiated intestinal tumor formation. However, littermates that were Apc+/- and either p21+/- or -/- had a significantly higher tumor incidence of 95 and 100%, respectively. In addition, the tumor frequency per mouse was increased by 23% in the Apc+/-,p21+/- mice and by >118% in the Apc+/-, p21-/- mice. The effect on tumor size was also striking: tumors in Apc+/-,p21+/- mice were 26% larger than the tumors in Apc+/-,p21+/+ mice at 36 weeks, and in the Apc+/-,p21-/- mice, the tumors were 74% larger.



View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. The incidence, frequency and size of gastrointestinal tumors in Apc+/-, p21+/+, +/-, or -/- mice fed AIN-76A diet for 36 weeks (*, P < 0.05, **, P < 0.01 comparison with Apc+/-, p21+/+ mice).

 
In vitro, the short-chain fatty acid butyrate, a physiological regulator of cell maturation in the intestinal tract (7 , 24) , elevates p21 expression in association with stimulation of cell cycle arrest, differentiation markers, and apoptosis (7) . Thus, p21 elevation in cultured intestinal cells mimics the in vivo association of elevated p21 expression with the major pathways of intestinal cell maturation seen after cells exit the proliferative compartment (3 , 4) . We, therefore, investigated how the targeted inactivation of p21 in vivo is associated with alterations in cell maturation pathways in the intestine. In the duodenum, the principal site of tumor formation in these mice regardless of genotype, absence of a single p21 allele in the Apc+/- mice increased proliferation by 25%, and in the absence of both alleles, proliferation increased by 38%. We also detected decreased apoptosis, measured by TUNEL, of 47% in the Apc+/-,p21+/- mice and 68% in the Apc+/-,p21-/- mice (Fig. 2)Citation . Figure 2Citation also shows that there is a major effect of the loss of a single or both p21 alleles on the ratio of proliferating to apoptotic cells in the duodenum. An important observation was that the increased proliferation and decreased apoptosis were not seen in the mucosa of the proximal colon of the Apc+/-,p21-/- mice compared with Apc+/- littermates wild type for p21 (data not shown). Because tumors formed only in the small intestine in these Apc+/- mice, even in the absence of p21, the changes in proliferation and apoptosis were tightly associated with the risk for tumor development in the tissue.



View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. Proliferation and apoptotic index in the duodenal epithelia of Apc+/-,p21+/+, +/-, or -/- mice fed AIN-76A diet for 36 weeks (*, P < 0.05, **, P < 0.01 comparison with Apc+/-,p21+/+ mice).

 
We also investigated the effects of p21 on intestinal cell differentiation. We focused on the goblet or secretory cell lineage, because this lineage is often lost very early in aberrant crypt foci in humans at risk for development of colon cancer (26, 27, 28) , in mice treated with chemical carcinogens (27) , and in Apc1638+/- mice (27) . Figure 3Citation illustrates a comparison of Apc+/-,p21-/- mice with the Apc+/-,p21+/+ mice, showing a substantial decrease in goblet cells in the duodenal mucosa that could be detected by Alcian blue staining (Fig. 3, A and B)Citation or by immunohistochemistry with MCM antibody, which recognizes mature mucin (Fig. 3, C and D)Citation . Frequencies of Alcian blue- and MCM-positive cells were determined for six mice in each genetic group. Table 1Citation shows that the decrease in the number of these cells was approximately 25% in the p21+/- heterozygotes and 39% in the p21-/- homozygotes (P < 0.05 and P < 0.001, respectively, compared with p21 wild-type mice). Similar to the results for proliferation and apoptosis, no effect of the loss of p21 on goblet cell frequency was detected in the large intestine, where tumors do not form (not shown).



View larger version (145K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 3. Identification of goblet cells in the duodenal epithelia of Apc+/-,p21+/+ or -/- mice fed AIN-76A diet for 36 weeks. Detection of goblet cells was by Alcian blue staining (A, B) or immunohistochemistry with an antibody (MCM; C, D) that recognizes mature murine mucin.

 

View this table:
[in this window]
[in a new window]

  		Table 1 Alcian blue and MCM staining in the duodenum of Apc+/-, p21+/+, +/-, or -/- mice fed AIN-76A diet

 
The effects of p21 inactivation in the flat mucosa of the intestine at the anatomical site of tumor formation suggests that loss of p21 plays a role early in the development of tumors initiated by the Apc mutation. A Western-style diet that mimics the human dietary intake of high fat and phosphate and low calcium and vitamin D, which are risk factors for colon cancer, also enhances tumor formation in the Apc1638+/- mouse, but this has been reported to be attributable to later effects on tumor promotion (29 , 30) .

If the p21 and a Western-style diet indeed act at different times during Apc-initiated tumor formation, we would hypothesize that the effects of the two would be additive and independent. To test this, mice that were Apc+/-,p21+/+, +/-, or -/- were fed the Western-style diet. We found a striking effect on intestinal tumor formation first reflected in the survival of the animals. Apc1638+/- mice that were wild type for p21 and fed the defined AIN-76A diet developed intestinal tumors (i.e., Fig. 1Citation ) but survived to 36 weeks of age (Fig. 4)Citation . Littermates that were Apc+/- and either p21+/- or -/- fed AIN-76A diet died somewhat earlier, coincident with the increase in tumor number and growth, and this was statistically significant for the Apc+/-,p21-/- group compared with Apc+/-,p21+/+ (P < 0.004). However, when fed the Western-style diet, all of the animals showed decreased survival compared with the same genetic groups fed AIN-76A (Fig. 4)Citation . For each genetic group, the effects of the Western-style diet in reducing life span were highly significant (P < 0.02, 0.003, and 0.015 for Apc+/-,p21+/+, +/-, and -/-, respectively). Most dramatic was the effect of a combination of absence of both alleles of p21 and the Western-style diet. Fewer than 29% of these mice survived to 36 weeks, whereas for the wild-type p21 mice on the standard or Western diet, the survival rates were 100 and 75%, respectively. The difference in survival for Apc+/-,p21+/+ mice fed AIN-76A compared with the Apc+/-,p21-/- mice fed the Western-style diet was significant at the P < 0.0001 level.



View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 4. Survival of Apc+/-,p21+/+, +/-, or -/- mice fed AIN-76A or Western-style diet.

 
Because many of the animals on the Western-style diet died before 36 weeks of age or had to be killed early because of their tumors, the number and size of tumors for this experiment and a comparison to the mice fed AIN76A is presented only for those mice that survived to 36 weeks of age. Table 2Citation illustrates that for this subset, the frequency and size of the tumors was much greater for each p21 genotype fed the Western-style diet compared with those fed AIN76A. The effects of the Western-style diet appeared to be additive with the effects of the p21 mutation. For each p21 genetic group (wild type, heterozygotes, and homozygotes), tumor number and size were approximately double for the Western-style diet groups compared with the AIN76A diet groups (Table 2)Citation . As a result, the combination of the Western-style diet and the absence of both p21 alleles increased the number of tumors per mouse by 4.4-fold (P < 0.004) compared with p21 wild-type animals fed AIN-76A, and the size of the tumors increased by 3-fold (P < 0.001). This significant enhancement of Apc+/--initiated tumor formation by a combination of inactivation of p21 and a Western-style diet led to the highly significant decrease in life span for the mice shown in Figure 4Citation .


View this table:
[in this window]
[in a new window]

  		Table 2 The frequency and size of gastrointestinal tumors in Apc+/-, p21+/+, +/-, or -/- mice fed AIN-76A diet or Western-style diet

 

   DISCUSSION
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We have demonstrated that the p21 gene normally suppresses tumor formation initiated by inactivation of the Apc gene. Although the largest effects were seen when both alleles of p21 were absent, absence of a single allele had intermediate effects, and these effects in the p21+/- mice were significant for tumor incidence in mice fed AIN-76A, for tumor frequency and size in mice fed a Western-style diet, and for proliferation, apoptosis, and goblet cell differentiation in the duodenal mucosa. In this regard, related molecules, such as p53, which is a regulator of p21 expression, and p27kip1, like p21 an inhibitor of cyclin-dependent kinases, have also been reported to have a tumor-enhancing effect upon loss of a single allele (31 , 32) .

A Western-style high-risk diet increased tumor formation in the Apc1638+/- mice (30) , and a high-fat diet also increases tumor formation in Min mice (33) . In the present study, the combination of loss of p21 and the consumption of the Western-style diet were additive on tumor formation and together resulted in much more frequent and larger tumors. The result of this was a highly significant decrease in life span of the mice.

The fact that p21 inactivation and a Western-style diet were additive on Apc-initiated tumor formation and that p21 inactivation had pronounced effects on cell maturation in the duodenal mucosa, whereas a Western-style diet has been reported to affect tumor formation in later stages (30) , suggests that the absence of p21 and the Western-style diet acted at different stages and pathways of tumor development and were independent. A role for p21 early in Apc-initiated tumor development is also consistent with reports that Apc inactivation up-regulates c-myc through its effects in altering ß-catenin-Tcf signaling (19) and that c-myc in turn up-regulates cdk4 (20) , whose activity is inhibited by p21. Thus, our data support the suggestion that this pathway is important in the initiation of tumor formation by mutations in Apc.

These data have important implications for understanding prognosis of human colon cancer. Although p21 is not frequently lost during the development and progression of human colon tumors, it is down-regulated in expression (3 , 4) , and low expression of p21 in the tumors is an independent prognostic factor that is linked to poorer survival in colorectal cancer patients (21) . Our data on increased tumor formation with loss of p21 in mice are consistent with these clinical data, although it should be pointed out that in the mouse genetic model, p21 is also missing from the surrounding stromal cells, and there are as yet no data suggesting that p21 down-regulation is a characteristic of nonepithelial cells in tumors. It is potentially important that low p53 expression was not a prognostic marker in the clinical studies (21) , a fact that is perhaps consistent with a role for p21 in tumor suppression independent of p53 (34) , such as its p53-independent role in pathways of cell cycle arrest, differentiation, and/or apoptosis of leukemia cells (35 , 36) , muscle cells, (37) , or colonic cells treated with butyrate (7) or sulindac (9) . Moreover, the fact that mouse life span is most significantly reduced by a combination of a tumor-promoting diet and a genetic modifier of Apc-initiated tumor formation suggests that dietary alterations in patients undergoing treatment for colon cancer might be effective in improving either disease-free and/or overall survival, especially in an adjuvant setting when patients have been surgically cured of disease and the primary goal is prevention of recurrence or metastasis.

We have found gene dosage-dependent effects of the absence of p21 on increasing cell proliferation and decreasing apoptosis and on reducing the number of mature goblet cells in the mucosa of Apc+/- mice that are specifically linked to the site of tumor formation (duodenum versus proximal colon). We believe the effects on proliferation in the mucosa are more important than the effects on apoptosis, because, as we have previously reported, the number of apoptotic cells is very low in the mucosa, and elimination of apoptosis by genetic elimination of short-chain fatty acid metabolism is ineffective in producing colon tumors (24) . However, the percentage change in apoptotic cells with loss of p21 is larger than the percentage change in proliferating cells, and the ratio between proliferating and apoptotic cells both in the mucosa and in the initiated tumor may be crucial elements in determining how tumors form and respond to dietary factors that modulate tumor formation.

The loss of p21 expression may be linked to the decrease in goblet cells attributable to the continued proliferation of cells that prevents their differentiation. Alternatively, p21 could have a more specific role in regulating lineages of differentiation in the intestinal mucosa than that which is presently understood. However, regardless of the mechanism by which goblet cells are depleted by the loss of p21, it is particularly significant that loss of this lineage and mucin secretion is a characteristic of early, preneoplastic aberrant crypt foci in patients who are at risk for developing colon cancer, in rodents treated with colon-specific carcinogens, and in the Apc1638+/- mouse and thus may be an important factor in the promotion of these early lesions (24, 25, 26) .

There are clearly profound interactions between diet and genetics in the development and progression of colorectal cancer (30 , 33 , 38 , 39) . Our finding that the absence of p21 and a Western-style diet can significantly increase tumor formation in combination to a greater extent than either does alone again demonstrates the importance of considering both dietary and genetic factors in tumor formation, in chemoprevention, and in therapy.


   ACKNOWLEDGMENTS
 
We would like to thank P. Leder and colleagues for supplying the p21-/- mice.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by NIH Grants CA75246 and PO CA13330. Back

2 To whom requests for reprints should be addressed, at Department of Oncology, Albert Einstein Cancer Center, Montefiore Hospital, 111 East 210th Street, Bronx, NY 10467. Phone: (718) 920-4663; Fax: (718) 882-4464; E-mail: augen{at}aecom.yu.edu Back

3 The abbreviations used are: TUNEL, terminal deoxynucleotidyl transferase-mediated nick end labeling; MCM, murine colonic mucin. Back

Received 6/30/00. Accepted 11/13/00.


   REFERENCES
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.[Medline]
  2. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.[Medline]
  3. El-Deiry W. S., Tokino T., Waldman T., Oliner J. D., Velculescu V. E., Burrell M., Hill D. E., Healy E., Rees J. L., Hamilton S. R., Kinzler K. W., Vogelstein B. Topological control of p21waf1/cip1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.[Abstract/Free Full Text]
  4. Polyak K., Hamilton S. R., Vogelstein B., Kinzler K. W. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am. J. Pathol., 149: 381-387, 1996.[Abstract]
  5. Waldman T., Kinzler K. W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.[Abstract/Free Full Text]
  6. Waldman T., Lengauer C., Kinzler K. W., Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.[Medline]
  7. Heerdt B. G., Houston M. A., Anthony G. M., Augenlicht L. H. Mitochondrial membrane potential in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res., 58: 2869-2875, 1998.[Abstract/Free Full Text]
  8. Archer S. Y., Meng S., Shei A., Hodin R. A. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA, 95: 6791-6796, 1998.[Abstract/Free Full Text]
  9. Goldberg Y., Nassif I. I., Pittas A., Tsai L-L., Dynlacht B. D., Rigas B., Shiff S. J. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene, 12: 893-901, 1996.[Medline]
  10. Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.[Medline]
  11. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J. P., Sedivy J. M., Kinzler K. W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Washington DC), 282: 1497-1501, 1998.[Abstract/Free Full Text]
  12. Deng C., Zhang P., Harper J. W., Elledge S. J., Leder P. Mice lacking p21cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.[Medline]
  13. Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.[Medline]
  14. Moser A. R., Pitot H. C., Dove W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Washington DC), 247: 322-324, 1990.[Abstract/Free Full Text]
  15. Su L-K., Kinzler K. W., Vogelstein B., Preisinger A. C., Moser A. R., Luongo C., Gould K. A., Dove W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (Washington DC), 256: 668-670, 1992.[Abstract/Free Full Text]
  16. Fodde R., Edelmann W., Yang K., van Leeuwen C., Carlson C., Renault B., Breukel C., Alt E., Lipkin M., Khan P. M., Kucherlapati R. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA, 91: 8969-8973, 1994.[Abstract/Free Full Text]
  17. Smits R., Kartheuser A., Jagmohan-Changur S., Leblanc V., Breukel C., de Vries A., van Kranen H., van Krieken J. H., Williamson S., Edelmann W., Kucherlapati R., Khan P. M., Fodde R. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis (Lond.), 18: 321-327, 1997.[Abstract/Free Full Text]
  18. Yang K., Edelmann W., Fan K., Lau K., Kolli V. R., Fodde R., Khan P. M., Kucherlapati R., Lipkin M. A mouse model of human familial adenomatous polyposis. J. Exp. Zool., 277: 245-254, 1997.[Medline]
  19. He T-C., Sparks A. B., Rago C., Hermeking H., Zawel L., da Costa L. T., Morin P. J., Vogelstein B., Kinzler K. W. Identification of c-MYC as a target of the APC pathway. Science (Washington DC), 281: 1509-1512, 1998.[Abstract/Free Full Text]
  20. Hermeking H., Rago C., Schuhmacher M., Li Q., Barrett J. F., Obaya A. J., O’Connell B. C., Mateyak M. K., Tam W., Kohlhuber F., Dang C. V., Sedivy J. M., Eick D., Vogelstein B., Kinzler K. W. Identification of CDK4 as a target of c-MYC. Proc. Natl. Acad. Sci. USA, 97: 2229-2234, 2000.[Abstract/Free Full Text]
  21. Zirbes T. K., Baldus S. E., Moenig S. P., Nolden S., Kunze D., Shafizadeh S. T., Schneider P. M., Thiele J., Hoelscher A. H., Dienes H. P. Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int. J. Cancer, 89: 14-18, 2000.[Medline]
  22. Newmark H. L., Lipkin M., Maheshwari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J. Natl. Cancer Inst. (Bethesda), 82: 491-496, 1990.[Abstract/Free Full Text]
  23. Newmark H. L., Lipkin M., Maheshwari N. Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). Am. J. Clin. Nutr., 54(Suppl.): 209S-214S, 1991.[Abstract/Free Full Text]
  24. Augenlicht L. H., Anthony G. M., Chruch T. L., Edelmann W., Kucherlapati R., Yang K. Y., Lipkin M., Heerdt B. G. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res., 59: 6005-6009, 1999.[Abstract/Free Full Text]
  25. Van Klinken J-W., Einerhand A. W. C., Duits L. A., Makkink M. K., Tytgat K. M. A. J., Renes I. B., Verburg M., Buller H. A., Dekker J. Gastrointestinal expression and partial cDNA cloning of murine Muc2. Am. J. Physiol., 276: G115-G124, 1999.[Abstract/Free Full Text]
  26. Pretlow T. P., Barrow B. J., Ashton W. S., O’Riordan M. A., Pretlow T. G., Jurcisek J. A., Stellato T. A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51: 1564-1567, 1991.[Abstract/Free Full Text]
  27. Pretlow T. P., Siddiki B., Augenlicht L. H., Pretlow T. G., Kim Y. S. Aberrant crypt foci (ACF)—earliest recognized players or innocent bystanders in colon carcinogenesis Schmiegel W. eds. . Colorectal Cancer: Molecular Mechanisms, Premalignant State, and Its Prevention, : 67-82, Kluwer Academic Publishers Lancaster, England 1999.
  28. Otori K., Sugiyama K., Hasebe T., Fukushima S., Esumi H. Emergence of adenomatous aberrant crypt foci from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res., 55: 4743-4746, 1995.[Abstract/Free Full Text]
  29. Risio M., Lipkin M., Newmark H., Yang K., Rossini F. P., Steele V. E., Boone C. W., Kelloff G. J. Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in the mouse colon. Cancer Res., 56: 4910-4916, 1996.[Abstract/Free Full Text]
  30. Yang K., Edelmann W., Fan K., Lau K., Leung D., Newmark H., Kucherlapati R., Lipkin M. Dietary modulation of carcinoma development in a mouse model for human familial polyposis. Cancer Res., 58: 5713-5717, 1998.[Abstract/Free Full Text]
  31. Venkatachalam S., Shi Y-P., Jones S. N., Vogel H., Bradley A., Pinkel D., Donehower L. A. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J., 17: 4657-4667, 1998.[Medline]
  32. Fero M. L., Randel E., Gurley K. E., Roberts J. M., Kemp C. J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (Lond.), 396: 177-180, 1998.[Medline]
  33. Wasan H. S., Novelli M., Bee J., Bodmer W. F. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc. Natl. Acad. Sci. USA, 94: 3308-3313, 1997.[Abstract/Free Full Text]
  34. Michieli P., Chedid M., Lin D., Pierce J. H., Mercer W. E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.[Abstract/Free Full Text]
  35. Jiang H., Lin J., Su Z., Collart F. R., Huberman E., Fisher P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.[Medline]
  36. Zhang W., Grasso L., McClain C. D., Gambel A. M., Cha Y., Travali S., Deisseroth A. B., Mercer W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.[Abstract/Free Full Text]
  37. Parker S. B., Eichele G., Zhang P., Rawls A., Sands A. T., Bradley A., Olson E. N., Harper J. W., Elledge S. J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.[Abstract/Free Full Text]
  38. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. (Bethesda), 66: 1191-1308, 1981.
  39. Lipkin M., Reddy B., Newmark H., Lamprecht S. A. Dietary factors in human colorectal cancer. Annu. Rev. Nutr., 19: 545-586, 1999.[Medline]



This article has been cited by other articles:


Home page
 J. Nutr.Home page
I. Erdelyi, N. Levenkova, E. Y. Lin, J. T. Pinto, M. Lipkin, F. W. Quimby, and P. R. Holt
Western-Style Diets Induce Oxidative Stress and Dysregulate Immune Responses in the Colon in a Mouse Model of Sporadic Colon Cancer
J. Nutr., November 1, 2009; 139(11): 2072 - 2078.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. J. George, M. A. Sturmoski, R. May, S. M. Sureban, B. K. Dieckgraefe, S. Anant, and C. W. Houchen
Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury
Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G245 - G254.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
I. Eude-Le Parco, G. Gendronneau, T. Dang, D. Delacour, V. L Thijssen, W. Edelmann, M. Peuchmaur, and F. Poirier
Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice
Glycobiology, January 1, 2009; 19(1): 68 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Yang, N. Kurihara, K. Fan, H. Newmark, B. Rigas, L. Bancroft, G. Corner, E. Livote, M. Lesser, W. Edelmann, et al.
Dietary Induction of Colonic Tumors in a Mouse Model of Sporadic Colon Cancer
Cancer Res., October 1, 2008; 68(19): 7803 - 7810.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
R. B. Halberg, X. Chen, J. M. Amos-Landgraf, A. White, K. Rasmussen, L. Clipson, C. Pasch, R. Sullivan, H. C. Pitot, and W. F. Dove
The Pleiotropic Phenotype of Apc Mutations in the Mouse: Allele Specificity and Effects of the Genetic Background
Genetics, September 1, 2008; 180(1): 601 - 609.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. P. Kunte, R. K. Wali, J. L. Koetsier, and H. K. Roy
Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase
Mol. Cancer Ther., July 1, 2008; 7(7): 1797 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Bi, C. Tong, A. Dockendorff, L. Bancroft, L. Gallagher, G. Guzman, R. V. Iozzo, L. H. Augenlicht, and W. Yang
Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation
Carcinogenesis, July 1, 2008; 29(7): 1435 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. C. Crim, L. M. Sanders, M. Y. Hong, S. S. Taddeo, N. D. Turner, R. S. Chapkin, and J. R. Lupton
Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet
Carcinogenesis, July 1, 2008; 29(7): 1415 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Li, J. E. Lin, I. Chervoneva, S. Schulz, S. A. Waldman, and G. M. Pitari
Homeostatic Control of the Crypt-Villus Axis by the Bacterial Enterotoxin Receptor Guanylyl Cyclase C Restricts the Proliferating Compartment in Intestine
Am. J. Pathol., December 1, 2007; 171(6): 1847 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Klampfer, J. Huang, S. Shirasawa, T. Sasazuki, and L. Augenlicht
Histone Deacetylase Inhibitors Induce Cell Death Selectively in Cells That Harbor Activated kRasV12: The Role of Signal Transducers and Activators of Transcription 1 and p21
Cancer Res., September 15, 2007; 67(18): 8477 - 8485.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Tong, Z. Yin, Z. Song, A. Dockendorff, C. Huang, J. Mariadason, R. A. Flavell, R. J. Davis, L. H. Augenlicht, and W. Yang
c-Jun NH2-Terminal Kinase 1 Plays a Critical Role in Intestinal Homeostasis and Tumor Suppression
Am. J. Pathol., July 1, 2007; 171(1): 297 - 303.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. H. Augenlicht, W. Yang, J. Mariadason, A. Velcich, L. Klampfer, M. Lipkin, and K. Yang
Interaction of Genetic and Dietary Factors in Mouse Intestinal Tumorigenesis
J. Nutr., October 1, 2006; 136(10): 2695S - 2696S.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. J. Wilson, D.-S. Byun, N. Popova, L. B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L. H. Augenlicht, and J. M. Mariadason
Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer
J. Biol. Chem., May 12, 2006; 281(19): 13548 - 13558.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. H. Augenlicht
Pathways in Nutritional Modulation of Homeostasis and Tumorigenesis
J. Nutr., December 1, 2005; 135(12): 3025S - 3026S.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
K. Yang, W. Yang, J. Mariadason, A. Velcich, M. Lipkin, and L. Augenlicht
Dietary Components Modify Gene Expression: Implications for Carcinogenesis
J. Nutr., November 1, 2005; 135(11): 2710 - 2714.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Yang, L. Bancroft, J. Liang, M. Zhuang, and L. H. Augenlicht
p27kip1 in Intestinal Tumorigenesis and Chemoprevention in the Mouse
Cancer Res., October 15, 2005; 65(20): 9363 - 9368.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P.-C. Chen, S. Dudley, W. Hagen, D. Dizon, L. Paxton, D. Reichow, S.-R. Yoon, K. Yang, N. Arnheim, R. M. Liskay, et al.
Contributions by MutL Homologues Mlh3 and Pms2 to DNA Mismatch Repair and Tumor Suppression in the Mouse
Cancer Res., October 1, 2005; 65(19): 8662 - 8670.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. C. Shen, H. Heng, Y. Wang, S. Lu, G. Liu, C.-X. Deng, S.C. Brooks, and Y. A. Wang
ATM and p21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development
Cancer Res., October 1, 2005; 65(19): 8747 - 8753.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Kallay, G. Bises, E. Bajna, C. Bieglmayer, W. Gerdenitsch, I. Steffan, S. Kato, H.J. Armbrecht, and H. S. Cross
Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention
Carcinogenesis, September 1, 2005; 26(9): 1581 - 1589.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
W. Yang, A. Velcich, I. Lozonschi, J. Liang, C. Nicholas, M. Zhuang, L. Bancroft, and L. H. Augenlicht
Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice
Am. J. Pathol., April 1, 2005; 166(4): 1239 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. M. Harris and V. L. W. Go
Vitamin D and Colon Carcinogenesis
J. Nutr., December 1, 2004; 134(12): 3463S - 3471S.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Chen, J. Turner, S. McCarthy, M. Scaltriti, S. Bettuzzi, and T. J. Yeatman
Clusterin-Mediated Apoptosis Is Regulated by Adenomatous Polyposis Coli and Is p21 Dependent but p53 Independent
Cancer Res., October 15, 2004; 64(20): 7412 - 7419.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Hulit, C. Wang, Z. Li, C. Albanese, M. Rao, D. Di Vizio, S. Shah, S. W. Byers, R. Mahmood, L. H. Augenlicht, et al.
Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice
Mol. Cell. Biol., September 1, 2004; 24(17): 7598 - 7611.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. A. Milner
Molecular Targets for Bioactive Food Components
J. Nutr., September 1, 2004; 134(9): 2492S - 2498S.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
O. Bashir, A.J. FitzGerald, and R.A. Goodlad
Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse
Carcinogenesis, August 1, 2004; 25(8): 1507 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. P. Pretlow, W. Edelmann, R. Kucherlapati, T. G. Pretlow, and L. H. Augenlicht
Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele
Am. J. Pathol., November 1, 2003; 163(5): 1757 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. A. Milner
Incorporating Basic Nutrition Science into Health Interventions for Cancer Prevention
J. Nutr., November 1, 2003; 133(11): 3820S - 3826.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Yang, L. Bancroft, C. Nicholas, I. Lozonschi, and L. H. Augenlicht
Targeted Inactivation of p27kip1 Is Sufficient for Large and Small Intestinal Tumorigenesis in the Mouse, Which Can Be Augmented by a Western-Style High-Risk Diet
Cancer Res., August 15, 2003; 63(16): 4990 - 4996.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. H. Augenlicht, A. Velcich, L. Klampfer, J. Huang, G. Corner, M. Aranes, C. Laboisse, B. Rigas, M. Lipkin, K. Yang, et al.
Application of Gene Expression Profiling to Colon Cell Maturation, Transformation and Chemoprevention
J. Nutr., July 1, 2003; 133(7): 2410S - 2416.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. J. Jackson, R. W. Engelman, D. Coppola, A. B. Cantor, W. Wharton, and W. J. Pledger
p21Cip1 Nullizygosity Increases Tumor Metastasis in Irradiated Mice
Cancer Res., June 15, 2003; 63(12): 3021 - 3025.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Yang, K. Fan, N. Kurihara, H. Shinozaki, B. Rigas, L. Augenlicht, L. Kopelovich, W. Edelmann, R. Kucherlapati, and M. Lipkin
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations
Carcinogenesis, March 1, 2003; 24(3): 605 - 611.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. H. Augenlicht, J. M. Mariadason, A. Wilson, D. Arango, W. Yang, B. G. Heerdt, and A. Velcich
Short Chain Fatty Acids and Colon Cancer
J. Nutr., December 1, 2002; 132(12): 3804S - 3808.
[Abstract] [Full Text] [PDF]

Home page
 CROBMHome page
W. C. Weinberg and M. F. Denning
P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE
Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 453 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. J. Bearss, R. J. Lee, D. A. Troyer, R. G. Pestell, and J. J. Windle
Differential Effects of p21WAF1/CIP1 Deficiency on MMTV-ras and MMTV-myc Mammary Tumor Properties
Cancer Res., April 1, 2002; 62(7): 2077 - 2084.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Martin-Caballero, J. M. Flores, P. Garcia-Palencia, and M. Serrano
Tumor Susceptibility of p21Waf1/Cip1-deficient Mice
Cancer Res., August 1, 2001; 61(16): 6234 - 6238.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Yang, A. Velcich, J. Mariadason, C. Nicholas, G. Corner, M. Houston, W. Edelmann, R. Kucherlapati, P. R. Holt, and L. H. Augenlicht
p21WAF1/cip1 Is an Important Determinant of Intestinal Cell Response to Sulindac in Vitro and in Vivo
Cancer Res., August 1, 2001; 61(16): 6297 - 6302.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, W. C.
Right arrow Articles by Augenlicht, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, W. C.
Right arrow Articles by Augenlicht, L. H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online